Markets.com Logo

ADVM

$--
--%
1d
1w
1m

Analysis and statistics

  • Open
    2.931$
  • Previous Close
    2.9957$
  • 52 Week Change
    6.78$
  • Day Range
    -0.06$
  • 52 Week High/Low
    1.78$ - 8.56$
  • Dividend Per Share
    --
  • Market cap
    61 484 K$
  • EPS
    -2.34
  • Beta
    0.771
  • Volume
    --

About

ADVM.US is the stock ticker symbol for Adverum Biotechnologies, Inc. Adverum Biotechnologies is a clinical-stage gene therapy company committed to discovering and developing new medicines that offer durable therapeutic benefits to patients suffering from ocular and rare diseases. The company's gene therapy platform is designed to provide long-lasting efficacy by enabling the patient's own cells to produce a therapeutic protein, thereby reducing the need for repeat administrations.
NBIS Stock Outlook for 2026: What will be the future of Nebius Group?

NBIS Stock Outlook for 2026: What will be the future of Nebius Group?

Frances Wang|--
Commodity market today: Will Gold (XAU/USD) and Silver (XAG) hit new highs?

Commodity market today: Will Gold (XAU/USD) and Silver (XAG) hit new highs?

Frances Wang|--
RGTI stock crashed 7% today: what’s happening with Rigetti Computing?

RGTI stock crashed 7% today: what’s happening with Rigetti Computing?

Frances Wang|--
Gold price analysis: XAU/USD price today, how high will gold go in 2026?

Gold price analysis: XAU/USD price today, how high will gold go in 2026?

Frances Wang|--
Technology stock to watch in 2026: What is the new NVDA stock price target?

Technology stock to watch in 2026: What is the new NVDA stock price target?

Frances Wang|--
BMNR stock up 9% today: what’s going on with BitMine Immersion Technologies?

BMNR stock up 9% today: what’s going on with BitMine Immersion Technologies?

Frances Wang|--
Solana (SOL) price analysis: What will SOL/USD be worth in 2026?

Solana (SOL) price analysis: What will SOL/USD be worth in 2026?

Frances Wang|--

Factors

Clinical Trial Results: Positive clinical trial data for Adverum Biotechnologies' gene therapy candidates typically leads to stock price increases, while negative or inconclusive results often cause price declines. Regulatory Decisions: FDA decisions regarding Adverum's investigational therapies, such as approval, rejection, or requests for additional data, significantly impact investor sentiment and stock valuation. Competition: The presence of competing gene therapies or alternative treatments for the same indications affects Adverum's market potential and therefore its stock price. Financial Performance: Adverum's cash position, burn rate, and ability to secure funding influence investor confidence and stock performance. Market Conditions: Broader market trends in the biotechnology sector and overall economic conditions can impact Adverum's stock price, regardless of company-specific news.

People Also Watch

Latest news

ESMA Expansion Sparks Crypto, Fintech Slowdown Concerns in EU

Noah Lee|--

Bitcoin's 'Santa' Rally: Fed Rate Decision and 2026 Outlook

Noah Lee|--

Western Union Unveils Stable Card, Stablecoin Strategy to Combat Inflation

Liam James|--

Latest Education Articles

A Complete Guide to Cryptos: How to Invest in Crypto as A BEGINNER In 2026?

A Complete Guide to Cryptos: How to Invest in Crypto as A BEGINNER In 2026?

Ghko B|--
Contracts for Difference explained: What is CFD trading, how do CFDs work?

Contracts for Difference explained: What is CFD trading, how do CFDs work?

Ghko B|--
Financial market for beginners: How financial markets work, how to invest?

Financial market for beginners: How financial markets work, how to invest?

Ghko B|--